论文部分内容阅读
Up-regulated expression of anti-apoptotic molecule BRE (TNFRSF1A-modulator/BRCC45) in hepatocellular
【机 构】
：
Joint JNU-CUHK Key lab for Regenerative Medicine,JiNan University,Guang Zhou,Guang Dong,China
【出 处】
：
2012医学科学前沿暨第二届个体化治疗与抗肿瘤药物研究新趋向研讨会
【发表日期】
：
2012年11期
其他文献
A new granding system for male erectile dysfunction (ED) on the selection of its therapeutic modalit
Objective:To investigate a reasonable pattern of goal diagnosis and therapy for male erectile dysfunction.Materials and methods:196male patients suffered with erectile dysfunction were accepted and di
会议
Effect of dicycloplatin,a novel platinum chemotherapeutical drug,on inhibiting cell growth and induc
Dicycloplatin,a new supramolecular platinum antitumor drug which was formed by one molecule carboplatin and one molecule 1,1-ring succinic acid via the effect of hydrogen bond.In this study,we investi
Imidazopyridine CCT129202 is an inhibitor of Aurora kinase activity and displays favorable antineoplastic effect in preclinical studies.Here,we investigated the enhanced effect of CCT129202 on the cyt
Cyclin-dependent kinase 7/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor α
Purpose:The "gate-keeper" mutations T6741 PDGFRα in hypereosinophilic syndrome (HES) and T3151 Bcr-Abl in chronic myeloid leukemia (CML),are resistant to imatinib and the second-generation small molec
会议
SAHA and PJ 1548,a Novel Tyrosine Kinase Inhibitor Synergistically Induce Apoptosis in Imatinib-Resi
Limited treatment options are available for chronic myeloid leukemia (CML) patients who develop imatinib mesylate resistance particularly in patients with gatekeep mutant Bcr-Abl such as T3151.Compoun
会议
Curcumin and its Derivatives Potently Inhibits the T3151 Mutant and Overcomes Mutation-Based Resista
Inhibition of BCR-ABL by imatinib induces durable responses in many patients with chronic myeloid leukemia (CML),but resistance attributable to kinase domain mutations can lead to relapse.Mutation of
会议
Hsp90 N-terminal inhibitor 17-AAG and C-terminal inhibitor cisplatin synergistically eradicates Bcr-
Hsp90 is a ubiquitous molecular chaperone that regulates over 200 client proteins involved in multiple growth and signaling pathways,which are targets for chemotherapeutic strategies.Thus,Hsp90s role
会议
MTA3 and the Mi-2/NuRD complex regulates EMT in esophageal squamous cell carcinoma through chromatin
Epithelial-mesenchymal transition (EMT) is a key regulator for morphogenesis during embryonic development and the essential contribution of the EMT to carcinoma progression is the loss of their epithe
会议
Overexpression of AIB1 in Papillary Thyroid Carcinoma Positively Correlates with Lymph Node Metastas
Background:AIB1,a new oncogenic coactivator,is commonly overexpressed and amplified in variety of human cancers.The status of AIB1 expression in papillary thyroid carcinoma (PTC) and its clinical sign
会议
Upregulation of Orai(l) Contributes To Excessive Cell Proliferation and Migration in Esophageal Squa
Objective:Store-operated Ca2+ entry (SOCE),an important Ca2+ signaling pathway,has been shown to involve into a diversity of cellular processes,including cell proliferation,apoptosis,tumor migration a